VIVOCannabisLogo.jpg
ABcann Global Appoints New Independent Chair
17 oct. 2017 07h00 HE | ABcann Medicinals
NAPANEE, Ontario, Oct. 17, 2017 (GLOBE NEWSWIRE) -- ABcann Global Corporation (TSX-V:ABCN) (“ABcann” or the “Company”) today announces that Ken Clement, founder and Executive Chair, has decided to...
VIVOCannabisLogo.jpg
ABcann Global Appoints Barry Fishman as Chief Executive Officer
07 sept. 2017 08h00 HE | ABcann Medicinals
NAPANEE, Ontario, Sept. 07, 2017 (GLOBE NEWSWIRE) -- ABcann Global Corporation (TSX-V:ABCN) ("ABcann" or the "Company") is pleased to announce the appointment of Barry Fishman as Chief Executive...
VIVOCannabisLogo.jpg
ABcann Global files Q2 2017 Financial Results and Provides Operational Update
29 août 2017 19h28 HE | ABcann Medicinals
OTTAWA, Aug. 29, 2017 (GLOBE NEWSWIRE) -- ABcann Global Corporation (TSX-V:ABCN) (“ABcann” or the “Company”) is pleased to release the Company's financial results for the three and six months ended...
VIVOCannabisLogo.jpg
ABcann Releases High Level CBD Product and Launches Initial Oils Strategy
28 août 2017 05h30 HE | ABcann Medicinals
OTTAWA, Aug. 28, 2017 (GLOBE NEWSWIRE) -- ABcann Global Corporation (TSX-V:ABCN) (“ABcann” or the “Company”) is pleased to announce the release of one of Canada's highest legal CBD:THC...
VIVOCannabisLogo.jpg
ABcann and Cannabis Wheaton Announce Closing of $15 Million Investment
02 août 2017 05h00 HE | ABcann Medicinals
OTTAWA, Aug. 02, 2017 (GLOBE NEWSWIRE) -- Further to their joint news release dated July 10, 2017, ABcann Global Corporation (TSX.V:ABCN) (Frankfurt:23Q) (OTCQB:ABCCF) (“ABcann”) and Cannabis...
VIVOCannabisLogo.jpg
ABcann Global Provides Construction and Expansion Update
26 juil. 2017 07h04 HE | ABcann Medicinals
OTTAWA, July 26, 2017 (GLOBE NEWSWIRE) -- ABcann Global Corporation (TSX-V:ABCN) (Frankfurt:23Q) (OTCQB:ABCCF) (the “Company”) is pleased to provide an update on the Company's construction and...
VIVOCannabisLogo.jpg
ABcann Global Announces Listing on the OTCQB Marketplace and the Frankfurt Stock Exchange
12 juil. 2017 08h00 HE | ABcann Medicinals
OTTAWA, July 12, 2017 (GLOBE NEWSWIRE) -- ABcann Global Corporation (TSX-V:ABCN) ("ABcann" or the "Company") is pleased to announce that its common shares have been approved for trading on the OTCQB...
VIVOCannabisLogo.jpg
ABcann and Cannabis Wheaton Announce Signing of Agreement for First Tranche $15 Million Investment
10 juil. 2017 01h27 HE | ABcann Medicinals; Cannabis Wheaton Income Corp.
OTTAWA, July 10, 2017 (GLOBE NEWSWIRE) -- Further to their joint news release dated May 29, 2017, ABcann Global Corporation (TSX.V:ABCN) (Frankfurt:23Q) (“ABcann”) and Cannabis Wheaton Income...
VIVOCannabisLogo.jpg
ABcann Global Announces Inclusion on the Horizons Medical Marijuana Life Sciences ETF
05 juil. 2017 08h55 HE | ABcann Medicinals
OTTAWA, July 05, 2017 (GLOBE NEWSWIRE) -- ABcann Global Corporation (TSX-V:ABCN) ("ABcann" or the "Company") is pleased to announce its inclusion in the Horizons Medical Marijuana Life Sciences ETF...
VIVOCannabisLogo.jpg
ABcann Global Recruits Dr. Michael Shannon as Chief Medical Consultant
29 juin 2017 09h19 HE | ABcann Medicinals
OTTAWA, June 29, 2017 (GLOBE NEWSWIRE) -- ABcann Global Corporation (TSX-V:ABCN) ("ABcann" or the "Company") is pleased to announce that it has retained the services of Dr. Michael Shannon as its...